Natera (NASDAQ:NTRA – Get Rating) had its target price cut by Piper Sandler from $80.00 to $70.00 in a research report released on Tuesday morning, The Fly reports. Several other brokerages have also recently commented on NTRA. Morgan Stanley boosted their price target on shares of Natera from $70.00 to $72.00 and gave the stock […]
Moore Capital Management LP acquired a new stake in shares of Natera, Inc. (NASDAQ:NTRA – Get Rating) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 75,000 shares of the medical research company’s stock, valued at approximately $3,013,000. Moore Capital Management LP owned approximately 0.08% […]
Artisan Partners Limited Partnership trimmed its stake in shares of Natera, Inc. (NASDAQ:NTRA – Get Rating) by 50.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 60,012 shares of the medical research company’s stock after selling 60,201 shares during the quarter. Artisan Partners Limited […]
Natera (NASDAQ:NTRA – Get Rating) had its price target hoisted by Robert W. Baird from $65.00 to $66.00 in a report released on Wednesday morning, The Fly reports. Other analysts have also recently issued reports about the stock. Piper Sandler increased their price target on shares of Natera from $70.00 to $80.00 in a research […]
FORA Capital LLC bought a new position in Natera, Inc. (NASDAQ:NTRA – Get Rating) in the fourth quarter, HoldingsChannel.com reports. The fund bought 8,296 shares of the medical research company’s stock, valued at approximately $333,000. A number of other large investors have also added to or reduced their stakes in NTRA. Belpointe Asset Management LLC […]